Latest Multi-drug-resistant tuberculosis Stories
Countries in the former Soviet Union and many regions of China are facing an epidemic of multi-drug resistant tuberculosis, according to a new report based on data from 90,000 patients in 83 countries.
According to a study reported in The Lancet on Saturday, a new antibiotic has passed a key phase in a test of drugs aimed at shortening the time to cure tuberculosis, offering a potential boon in the fight against TB.
The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.
Disease experts claim that efforts to fight HIV and tuberculosis must be paired in order to be most effective.
WASHINGTON, March 24 /PRNewswire-USNewswire/ -- Statement from Stephen J. Nolan, Chairman of the American Lung Association: One hundred and five years after Dr.
U.S. researchers said on Thursday that two existing drugs used in combination appear to offer great promise against the most dangerous form of tuberculosis.
A four-month treatment with the drug rifampin is better tolerated for tuberculosis than the nine-month treatment of isoniazid, Canadian researchers said. Dr.
Levels of drug-resistant tuberculosis in China are nearly twice the global average, researchers said. Research published in the journal BMC Infectious Diseases, said almost 10 percent of Chinese TB cases are resistant to the most effective first-line drugs. Susan van den Hof of the KNCV Tuberculosis Foundation in The Netherlands said China has joined the global project on anti-tuberculosis drug resistance surveillance, and investigated drug resistance in 10 provinces from 1996 to 2004. China...
New research on drug-resistant tuberculosis found that the hard-to-treat disease results in death for half of patients who get it.
- A volcanic mudflow.